Emergent BioSolutions Announces Retirement of Chief Financial Officer Richard S. Lindahl
Emergent BioSolutions announced that CFO Richard S. Lindahl will retire effective December 31, 2026. Frank Vargo, currently VP and treasurer with the company since 2018, becomes interim CFO on January 1, 2027, with Lindahl staying on as senior executive advisor through March 31, 2027 to support the handoff.
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.